O016/#233 Clinical and molecular characteristics of ariel3 patients who derived exceptional benefit from rucaparib maintenance treatment for high-grade ovarian cancer (HGOC)

Authors :: Giovanni Scambia
Andrew R Clamp
Robert L. Coleman
T Kwan
Robert W. Holloway
Nicoletta Colombo
Lara Maloney
M. Amenedo Gancedo
Alexandra Leary
Peter C.C. Fong
Carol Aghajanian
David M. O'Malley
Johanne I Weberpals
Sandra Goble
Ana Oaknin
Jonathan A. Ledermann
Andrew Dean
Domenica Lorusso
Amit M. Oza
Jeffrey C. Goh
Source :: Oral Abstracts.
Publication Year :: 2021
Publisher :: BMJ Publishing Group Ltd, 2021.

Subjects :: Oncology
medicine.medical_specialty
chemistry.chemical_compound
chemistry
business.industry
Internal medicine
medicine
Ovarian cancer
medicine.disease
Rucaparib
business

Full Text Access

Tools